Effects of antibiotic physicochemical properties on their release kinetics from biodegradable polymer microparticles

Sarita R Shah1, Allan M Henslee, Patrick P Spicer

  • 1Department of Bioengineering, Rice University, MS-142, 6100 Main St., Houston, Texas, 77005, USA.

Abstract

Insights

Antibiotic properties like molecular weight and charge significantly impact drug loading and release from poly(DL-lactic-co-glycolic acid) (PLGA) microparticles (MPs). This allows for predicting drug delivery behavior for improved antibiotic therapies.

Area of Science:

  • Biomaterials Science
  • Pharmaceutical Sciences
  • Drug Delivery

Background:

  • Poly(DL-lactic-co-glycolic acid) (PLGA) microparticles (MPs) are widely used for controlled drug release.
  • Understanding how antibiotic physicochemical properties influence PLGA MP performance is crucial for optimizing drug delivery systems.

Purpose of the Study:

  • To investigate the impact of antibiotic physicochemical properties on the characteristics of PLGA microparticles.
  • To analyze the effects on morphology, loading efficiency, size, release kinetics, and efficacy of antibiotics within PLGA MPs.

Main Methods:

  • Six antibiotics (cefazolin, ciprofloxacin, clindamycin, colistin, doxycycline, vancomycin) were loaded into PLGA MPs at 10% and 20% wt% using a double emulsion method.
  • Characterization included assessment of microparticle morphology, size, loading efficiency, in vitro release kinetics, and antibiotic efficacy.

Main Results:

  • Antibiotic molecular weight and charge significantly influenced loading efficiency and release kinetics from PLGA MPs.
  • Lower molecular weight (<600 Da) antibiotics showed biphasic release, while higher molecular weight (>1000 Da) antibiotics exhibited triphasic release.
  • All released antibiotics retained efficacy against susceptible strains, with release durations ranging from 17 to 49 days.

Conclusions:

  • The chemical nature of antibiotics is a key determinant of their behavior within PLGA microparticles.
  • These findings enable prediction of loading and release kinetics for antibiotic-loaded PLGA MPs, guiding formulation development.

Related Concept Videos

Modified-Release Drug Delivery Systems: Influencing Factors01:20

Modified-Release Drug Delivery Systems: Influencing Factors

Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
202
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
728
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
139
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
163
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
830